Evidence map›Paper›PMID 41754611›Full record

ArticleViruses2026

Next-Generation Sequencing Reveals Continued Circulation of Rare HIV-1 Subtypes in the Democratic Republic of the Congo and Refines the Estimate of the Emergence Dates of Three Subtypes.

Mark Anderson, Gregory S Orf, Vera Holzmayer, Ana Olivo, Barbara J Harris, Michael G Berg, Guixia Yu, Asmeeta Achari, Scot Federman, Charles Y Chiu and 4 more

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mark AndersonDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.
Gregory S OrfDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.ORCID 0000-0002-4853-8518
Vera HolzmayerDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.ORCID 0000-0003-0137-5763
Ana OlivoDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.
Barbara J HarrisDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.
Michael G BergDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.ORCID 0000-0003-0233-5819
Guixia YuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158, USA.
Asmeeta AchariDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158, USA.
Scot FedermanDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0001-8712-3131
Charles Y ChiuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158, USA.
Linda JamesFaculté de Médecine, Université Protestante au Congo, Kinshasa B.P. 4745, Democratic Republic of the Congo.
Samuel MampunzaFaculté de Médecine, Université Protestante au Congo, Kinshasa B.P. 4745, Democratic Republic of the Congo.
Gavin A ClohertyDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.
Mary A RodgersDiscovery Research, Abbott Laboratories, Abbott Park, IL 60064, USA.ORCID 0000-0001-8815-8651

Funding

Abbott NA
6 · The paper itself

Abstract

HIV-1 diversified for decades within the Democratic Republic of the Congo (DRC) before spreading globally in the early 1980s. Thus, the DRC is home to some of the most ancestral and diverse HIV-1 strains. Recent serosurveys conducted from 2017 to 2019 in Kinshasa, DRC, indicated high prevalence of HIV-1, yet sequence data is lacking from this period. Given the history of circulating rare HIV-1 subtypes in the DRC, a viral whole-genome sequencing study was conducted to determine current diversity in the greater Kinshasa area. Next-generation sequencing (NGS) through metagenomic and target enrichment methods was conducted on 197 specimens collected from 2017 to 2019. A large array of HIV subtypes (A, B, C, D, F1, G, H, J, and K), circulating recombinant forms (CRF01_AE, CRF02_AG, CRF05_DF, CRF11_cpx, CRF13_cpx, CRF25_cpx, CRF 45_cpx, and CRF92_C2U), unique recombinant forms, and unclassifiable sequences were observed, with many branching in basal positions within, or outside of, many subtypes on phylogenetic trees. Incorporating these new sequences into Bayesian inference of phylogeny pushes back the dates of the most recent common ancestors of HIV-1 group M and the rare subtypes G, H, and J by between 3 and 7 years each. The DRC continues to harbor diverse and rare HIV-1 subtypes that could challenge diagnostic tests, treatments, and vaccines. In addition to shifting subtype emergence dates, the sequences from our study are evidence that rare strains continue to circulate and should be regularly monitored.

Indexed as

HIV-1HIV InfectionsDemocratic Republic of the CongoGenetic VariationGenome, ViralGenotypeHigh-Throughput Nucleotide SequencingHumansPhylogenyBayesian inference of phylogenyHIV-1 genotypesHIV-1 subtypeshuman immunodeficiency virus 1next-generation sequencing

Identifiers

PMID41754611
PMCPMC12945268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.